We are live on
!
Find out more
TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Est. Return
58.09%
This Fund
S&P 500
This Quarter
Est. Return
+25.06%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$252M
AUM Growth
+$6.65M
(+2.7%)
Cap. Flow
-$26.7M
Cap. Flow
% of AUM
-10.6%
Top 10 Holdings %
Top 10 Hldgs %
83.32%
Holding
28
New
7
Increased
8
Reduced
5
Closed
6
Top Buys
| 1 |
Pacira BioSciences
PCRX
|
+$12.5M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$9.38M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
+$7.52M |
| 4 |
Medtronic
MDT
|
+$6.71M |
| 5 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$5.52M |
Top Sells
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
+$24.8M |
| 2 |
NovoCure
NVCR
|
+$22.4M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
+$17.9M |
| 4 |
Service Corp International
SCI
|
+$6.47M |
| 5 |
McKesson
MCK
|
+$5.52M |
Sector Composition
| 1 | Healthcare | 76.86% |
| 2 | Industrials | 11.02% |
| 3 | Consumer Discretionary | 1.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $33.9M | 13.45% |
3,550,000
+500,000
| +16% | +$5.52M |
|
|
2
Medtronic
MDT
$107B
| $31.9M | 12.66% |
350,000
+75,000
| +27% | +$6.71M |
|
|
SRCL
3
DELISTED
Stericycle Inc
SRCL
| $27.8M | 11.02% |
510,000
+85,000
| +20% | +$3.85M |
|
|
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $25.2M | 9.99% |
725,000
+325,000
| +81% | +$9.38M |
|
5
Lantheus
LNTH
$6.84B
| $23.3M | 9.23% |
950,000
-25,000
| -3% | -$500K |
|
6
Bio-Rad Laboratories Class A
BIO
$8.05B
| $19.9M | 7.89% |
65,000
+5,000
| +8% | +$1.35M |
|
7
Rigel Pharmaceuticals
RIGL
$775M
| $13.6M | 5.41% |
530,000
-20,000
| -4% | -$457K |
|
|
8
Pacira BioSciences
PCRX
$1.01B
| $12.2M | 4.84% |
+320,000
| New | +$12.5M |
|
9
AtriCure
ATRC
$1.81B
| $11.4M | 4.52% |
425,000
-175,000
| -29% | -$5.32M |
|
|
HOLX
10
DELISTED
Hologic
HOLX
| $10.9M | 4.32% |
225,000
+25,000
| +13% | +$1.13M |
|
|
NVRO
11
DELISTED
NEVRO CORP.
NVRO
| $10M | 3.97% |
+160,000
| New | +$7.52M |
|
|
CORV
12
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $7.58M | 3.01% |
2,400,000
+275,000
| +13% | +$890K |
|
13
Alkermes
ALKS
$8.72B
| $5.11M | 2.03% |
+140,000
| New | +$4.62M |
|
|
14
Service Corp International
SCI
$11B
| $4.82M | 1.91% |
120,000
-155,000
| -56% | -$6.47M |
|
|
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.23M | 1.68% |
3,000,000
+2,000,000
| +200% | +$2.8M |
|
|
HIND
16
Vyome Holdings
HIND
$15.4M
| – | – |
0
| – | – |
|
17
Thermo Fisher Scientific
TMO
$200B
| $2.74M | 1.09% |
+10,000
| New | +$2.49M |
|
|
STRM
18
DELISTED
Streamline Health Solutions
STRM
| $2.05M | 0.81% |
130,000
| – | – |
|
|
CMD
19
DELISTED
Cantel Medical Corporation
CMD
| $2.01M | 0.8% |
+30,000
| New | +$2.27M |
|
20
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $420K | 0.17% |
+4,000
| New | +$1.09M |
|
|
VSI
21
DELISTED
Vitamin Shoppe Inc.
VSI
| $93K | 0.04% |
13,158
-586,842
| -98% | -$3.46M |
|
|
MDCO
22
PUT
DELISTED
Medicines Co
MDCO
| $34K | 0.01% |
+1,714
| New | +$40.4K |
|
|
23
McKesson
MCK
$98.7B
| – | – |
-50,000
| Closed | -$5.52M |
|
|
24
NovoCure
NVCR
$1.87B
| – | – |
-670,000
| Closed | -$22.4M |
|
|
OPTN
25
DELISTED
OptiNose
OPTN
| – | – |
-20,000
| Closed | -$1.86M |
|
Similar funds
SCM
LBC
ICM
LCMP
GIP
STC
GC
DU